Previous studies have suggested that ANGPTL4 has great potential as a molecular marker in tumor diagnosis and patient prognosis, as it regulates tumor progression through various signaling pathways [13–15], including Extracellular signal-related kinases 1 and 2 (ERK1/2) [16, 17]. The gene discussed is MAPK3; the disease is neoplasm.